Sanofi Aventis – Multaq 2D

On June 26th, 2010, posted in: Media Demo by shaharm Comments Off

Sanofi-aventis 2D Clip – Sanofi-Aventis(EURONEXT: SAN and NYSE: SNY) announced today that the Cardiovascular and Renal Drugs Advisory Committee voted 10 to 3 in favor of the approval of Multaq® by the U.S. Food and Drug Administration (FDA) to treat patients with non-permanent atrial fibrillation (AF).

Comments are closed.